Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.5Revenue $M52.7Net Margin (%)1.5Z-Score3.6
Enterprise Value $M12.4EPS $0.1Operating Margin %1.0F-Score7
P/E(ttm))71.6Cash Flow Per Share $0Pre-tax Margin (%)5.0Higher ROA y-yY
Price/Book0.310-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsY
Price/Sales0.35-y EBITDA Growth Rate %0Current Ratio6.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)1.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)1.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M14.3ROI % (ttm)-19.4Gross Margin Increase y-yN

Gurus Latest Trades with BSPM

Number of guru portfolios checked: 56.

No Entry found!

BSPM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BSPM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wang RonghuaChairman, CEO, 10% Owner 2011-06-16Buy21,081$3.57-61.9 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-13Buy13,915$3.66-62.84 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-09Buy15,532$3.75-63.73 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-07Buy6,299$3.72-63.44 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-03Buy2,300$3.81-64.3 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-02Buy4,066$3.87-64.86 view
Wang RonghuaChairman, CEO, 10% Owner 2011-06-01Buy3,104$3.99-65.91 view
Pan ZibingCFO 2011-05-19Buy9,999$4.23-67.85 view

Press Releases about BSPM :

    Quarterly/Annual Reports about BSPM:

    News about BSPM:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: ANADIGICS Inc., Biostar Pharmaceuticals Inc., Astrotech Corp. May 30 2011 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Jul 25 2014
    BIOSTAR PHARMACEUTICALS, INC. Financials May 23 2014
    BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 15 2014
    Biostar Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results May 15 2014
    BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 31 2014
    Biostar Pharmaceuticals, Inc. Announces Full Year 2013 Financial Results Mar 31 2014
    Biostar Announces Execution of Agreement for $4.1 Million Registered Direct Offering of Shares of... Mar 10 2014
    BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Mar 10 2014
    Biostar Announces Execution of Agreement for $4.1 Million Registered Direct Offering of Shares of... Mar 10 2014
    China Biotech In Review: iKang Healthcare Planning $150 Million IPO In U.S. Mar 09 2014
    Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop... Mar 06 2014
    Biostar Pharmaceuticals to develop liver cancer drug with Chinese university Mar 06 2014
    Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop... Mar 06 2014
    Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating... Feb 20 2014
    BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 20 2014
    Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating... Feb 20 2014
    Biostar Held Its Strategic Development Seminar; Identified Development Planning for 2014 - 2016 Feb 16 2014
    Biostar Held Its Strategic Development Seminar; Identified Development Planning for 2014 - 2016 Feb 14 2014
    Biostar Pharmaceuticals, Inc. Announces the Designation of its PRC Operating Subsidiary as the... Jan 15 2014
    Biostar Pharmaceuticals, Inc. Announces the Designation of its PRC Operating Subsidiary as the... Jan 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide